Yüklüyor......
Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding
A 77-year-old man with atrial fibrillation and a CHA(2)DS(2)Vasc score of 6 for hypertension, age, diabetes, and previous stroke is brought to the emergency department with decreased level of consciousness. He is anticoagulated with rivaroxaban (a direct oral factor Xa inhibitor [FXaI]) and received...
Kaydedildi:
| Yayımlandı: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913461/ https://ncbi.nlm.nih.gov/pubmed/31808849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000074 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|